{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Liuqing Yang"}, {"accession": "MS:1000589", "name": "contact email", "value": "lyang7@mdanderson.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "The University of Texas MD Anderson Cancer Center"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Liuqing Yang"}, {"accession": "MS:1000589", "name": "contact email", "value": "lyang7@mdanderson.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "The University of Texas MD Anderson Cancer Center"}]}], "datasetFiles": [{"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_wt_IgG.dat"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_wt_IgG.raw"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_wt_Dmd.dat"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_wt_Dmd.raw"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_ko_IgG.dat"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_ko_IgG.raw"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_ko_Dmd.dat"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566/042117CL535_C2C12_H19_ko_Dmd.raw"}], "description": "Dystrophin proteomic regulation in Muscular Dystrophies (MD) remains unclear. We report that a long noncoding RNA (lncRNA) H19 associates with dystrophin. To investigate the biological roles of this interaction in vivo, we performed mass spectrometry analysis of dystrophin and its associated proteins in H19-proficient and -deficient C2C12 myotubes. Mass spectrometry data indicated that in H19-proficient myotubes, dystrophin associates with components of dystrophin-associated protein complex (DPC); however, in H19-deficient myotubes, dystrophin associated with UBA1, UB2G1, TRIM63 ubiquitin E3 ligase and ubiquitin. In H19-deficient myotubes, dystrophin was post-translationally modified with K48-linked poly-ubiquitination at Lys3577 (referred to as Ub-DMD). This mass spectrometry study demonstrated that lncRNA H19, associates with dystrophin and inhibits E3 ligase-dependent Ub-DMD formation and its subsequent proteasomal degradation. Based on this study, H19 RNA oligonucleotides conjugated with a muscle homing ligand Agrin (referred to as AGR-H19) and Nifenazone, a TRIM63-specific small molecule inhibitor, reverses the dystrophin degradation in iPSC-derived skeletal muscle cells from Becker Muscular Dystrophy patients. Furthermore,treatment of mdx mice with exon-skipping reagent, in combination with either AGR-H19 or Nifenazone, dramatically stablized dystrophin, preserved skeletal/cardiac muscle histology, and improved strength/heart function. In summary, this mass spectrometry study paves the way to meaningful targeted therapeutics for BMD and certain DMD patients.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD020566"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD020566"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD020566"}], "instruments": [{"accession": "MS:1001910", "name": "LTQ Orbitrap Elite"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Mouse, C2C12, H19, Dystrophin, DMD, BMD, AGR-H19, Nifenazone, LC-MS"}], "modifications": [{"accession": "MOD:00492", "name": "ubiquitination signature dipeptidyl lysine"}], "publications": [{"terms": [{"accession": "MS:1002858", "name": "Dataset with its publication pending"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus (Mouse)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}], "title": "Protein Identification and Post-translational Analysis of DMD and its associated Proteins in H19-proficient and -deficient Cells"}